| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.1 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.2 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |